Hyang Sook Lee

This inventor holds 19 USPTO granted patents and 9 published patent applications, plus 4 CIPO patents and 5 EPO patents. Top assignees: Intocell, Inc., Legochem Biosciences, Inc., Legochem Bioscience Ltd.. Active years: 2012-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hyang Sook Lee. Retrieved from https://idiyas.com/inventor/hyang-sook-lee

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 19 (Patent Applications = 9)

% Patents Active = 73.7

CIPO Patents = 4 (Patent Applications = 6)

EPO Patents = 5 (Patent Applications = 14)

Average Co-Inventor Count = 13.9

ph-index = 5

Forward Citations = 84(Granted Patents)

Company Filing History:

Legochem Biosciences, Inc.

patents

2 out of 4

Legochem Bioscience Ltd.

where one patent can have more than one assignee

Years Active: 2012-2026

Loading Chart...

19 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12551570 - Compounds comprising cleavable linker and uses thereof (2026-02-17),

2. 12479927 - Compounds comprising cleavable linker and uses thereof (2025-11-25),

3. 12274898 - Substituted benzodiazepines as antibody-drug conjugates (2025-04-14),

4. 12168060 - Antibody-drug conjugates comprising anti-B7-H3 antibodies (2024-12-17),

5. 11807628 - Benzodiazepine derivatives and uses thereof (2023-11-07),

6. 11753431 - Compounds comprising cleavable linker and uses thereof (2023-09-12),

7. 11084801 - Benzodiazepine derivatives and uses thereof (2021-08-10),

8. 11065343 - Compound bearing beta-galactoside-introduced self-immolative linker (2021-07-20),

9. 10980890 - Compounds comprising self-immolative group (2021-04-20),

10. 10383949 - Compounds comprising self-immolative group (2019-08-20),

11. 9993568 - Compounds comprising self-immolative group (2018-06-12),

12. 9919057 - Compounds comprising self-immolative group (2018-03-20),

13. 9630977 - Cephalosporin derivatives and pharmaceutical compositions thereof (2017-04-25),

14. 8846669 - Oxazolidinone derivative and medical composition containing same (2014-09-30),

15. 8809541 - Heterocyclic compound, and composition for treating inflammatory diseases using same (2014-08-19),

Title: The Innovative Journey of Hyang Sook Lee

Introduction

Hyang Sook Lee, an accomplished inventor based in Daejeon, South Korea, has made significant contributions to the field of biomedical research, particularly in the development of novel therapeutic agents. With an impressive portfolio of 16 patents, Lee has established himself as a prominent figure in innovation and biotechnology.

Latest Patents

Among his latest patents, Hyang Sook Lee has developed antibody-drug conjugates comprising anti-B7-H3 antibodies. This innovative work involves the creation of antibody-drug conjugates (ADCs) where one or more active agents are linked to an anti-B7-H3 antibody through a specialized linker. The disclosure emphasizes the potential of monoclonal antibodies and various fragments that specifically bind to B7-H3, along with methods for their application in therapeutic, diagnostic, and prophylactic scenarios.

Additionally, Lee has patented benzodiazepine derivatives, providing compositions capable of extending lifespan, along with methods for their use. These advancements not only highlight his innovative approach but also promise significant implications for health and longevity.

Career Highlights

Hyang Sook Lee has worked with reputable organizations, including Legochem Biosciences, Inc. and Intocell, Inc. His efforts at these companies have contributed to groundbreaking research that pushes the boundaries of current medical practices, showcasing his dedication to enhancing therapeutic solutions.

Collaborations

Throughout his career, Lee has collaborated with talented professionals such as Sung Ho Woo and Tae Kyo Park. These partnerships have fostered a productive environment for innovation, combining expertise to further the development of novel biomedical applications.

Conclusion

Hyang Sook Lee stands out as a key player in the realm of inventions, particularly in the areas of antibody development and lifespan extension. His substantial number of patents, along with his collaborations and work experience, cements his status as an influential inventor within the biotechnology sector. As he continues to push the frontiers of innovation, the implications of his work are sure to resonate in the fields of medicine and health for years to come.

Profile summary based on public USPTO records.